Lead researcher and Associate Professor Mike Lawrence examining modes for docking insulin into a three-dimensional structure of the human insulin receptor ectodomain in Melbourne. Photo: AFP Lead researcher and Associate Professor Mike Lawrence examining modes for docking insulin into a three-dimensional structure of the human insulin receptor ectodomain in Melbourne. Photo: AFP
Lead researcher and Associate Professor Mike Lawrence examining modes for docking insulin into a three-dimensional structure of the human insulin receptor ectodomain in Melbourne. Photo: AFP

Insulin breakthrough may end daily jabs for diabetics

Lead researcher and Associate Professor Mike Lawrence examining modes for docking insulin into a three-dimensional structure of the human insulin receptor ectodomain in Melbourne. Photo: AFP Lead researcher and Associate Professor Mike Lawrence examining modes for docking insulin into a three-dimensional structure of the human insulin receptor ectodomain in Melbourne. Photo: AFP
Lead researcher and Associate Professor Mike Lawrence examining modes for docking insulin into a three-dimensional structure of the human insulin receptor ectodomain in Melbourne. Photo: AFP
READ FULL ARTICLE